<DOC>
	<DOCNO>NCT01478360</DOCNO>
	<brief_summary>This study preliminary proof efficacy study AIN457 patient bronchial asthma poorly control current standard care .</brief_summary>
	<brief_title>Safety , Tolerability , Efficacy AIN457 Patients With Uncontrolled Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Adult patient asthma &gt; 1 year duration diagnose accord GINA guideline ( GINA 2010 ) . Daily treatment &gt; 1000μg beclomethasone dipropionate equivalent , plus long acting beta agonist ≥ 3 month prior Day 1 , stable least 4 week prior screen . Asthma adequately control current treatment Peripheral blood eosinophil count &lt; 400/μl screen Women childbearing potential unwilling use effective contraception study 16 week stop treatment . Use investigational drug time screening , within 30 day screen . Smokers</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Secukinumab</keyword>
	<keyword>Therapeutic Uses</keyword>
	<keyword>Respiratory</keyword>
	<keyword>Lung</keyword>
	<keyword>Pulmonary</keyword>
	<keyword>inhale</keyword>
	<keyword>corticosteroid</keyword>
</DOC>